Propiedad y actividad de insiders de Apogee Therapeutics, Inc. (APGE): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $135.07 |
| Capitalización | $8.4B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-03 | Fairmount Funds Management LLC | D-Return | 51,166 | $6.9M |
| 2026-09-03 | Fairmount Funds Management LLC | D-Return | 6,743,321 | |
| 2026-09-03 | Fairmount Funds Management LLC | D-Return | 47,758 | $812K |
| 2026-09-03 | Fairmount Funds Management LLC | D-Return | 10,370 | $455K |
| 2026-09-03 | Fairmount Funds Management LLC | D-Return | 14,461 | $602K |
| 2026-09-03 | Fairmount Funds Management LLC | D-Return | 7,657 | $651K |
| 2026-09-03 | McKenna Mark C. | D-Return | 20,000 | |
| 2026-09-03 | McKenna Mark C. | D-Return | 150,000 | $3.5M |
| 2026-09-03 | McKenna Mark C. | D-Return | 10,370 | $455K |
| 2026-09-03 | McKenna Mark C. | D-Return | 14,461 | $602K |
Balance (10 años)
| Año | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Caja y Equivalentes | $151.9M | $118.3M | $141.8M | $131.5M |
| Inversiones a Corto | 0 | $277.1M | $378.9M | $598.6M |
| Cuentas por Cobrar | 0 | $1.2M | $4.7M | $6.0M |
| Inventario | 0 | 0 | 0 | 0 |
| Activos Corrientes | $152.1M | $398.4M | $529.7M | $741.4M |
| Inmovilizado Material | 0 | $2.6M | $13.3M | $14.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 |
| Activos Totales | $152.1M | $401.4M | $754.0M | $937.1M |
| Cuentas por Pagar | $418000 | $2.1M | $1.1M | $1.2M |
| Deuda a Corto | 0 | $1.1M | $3.2M | 0 |
| Pasivos Corrientes | $10.0M | $20.6M | $28.6M | $27.9M |
| Deuda a Largo | 0 | 0 | 0 | $5.3M |
| Pasivos Totales | $10.0M | $21.5M | $37.2M | $33.3M |
| Reservas | -$39.8M | -$123.8M | -$305.9M | -$561.8M |
| Patrimonio Neto | $142.1M | $379.9M | $716.8M | $903.9M |
| Deuda Total | 0 | $2.0M | $11.8M | $8.8M |
| Deuda Neta | -$151.9M | -$393.4M | -$508.8M | -$721.3M |
| Capital Circulante | $142.1M | $377.9M | $501.2M | $713.5M |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 26.44 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 81.73 |
Rentabilidad
| Rentabilidad sobre capital | -29.88% |
| Rentabilidad sobre capital invertido | -25.23% |
| Rentabilidad sobre activos | -22.04% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: AAPG · CELC · CGON · CNTA · IRON · LEGN · RARE
Explorar sector: Healthcare · Biotechnology
Más secciones de APGE: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones